Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20940416 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis
Condition: Chronic Lymphocytic Leukemia
Interventions: Biological: Rituximab;   Drug: Fludarabine phosphate;   Other: Leukemic or stroma cells

Indicates status has not been verified in more than two years